Management of Benign Salivary Gland Conditions

Kody Bolk; Kurt Mueller; Neelam Phalke; Rohan R Walvekar

doi:10.1016/j.suc.2022.01.001

Management of Benign Salivary Gland Conditions

Surg Clin North Am. 2022 Apr;102(2):209-231. doi: 10.1016/j.suc.2022.01.001. Epub 2022 Mar 8.

Authors

Kody Bolk¹, Kurt Mueller¹, Neelam Phalke¹, Rohan R Walvekar²

Affiliations

¹ Department of Otolaryngology Head & Neck Surgery, Louisiana State University Health Sciences Center, 533 Bolivar Street, Suite 566 New, Orleans, LA 70112, USA.
² Department of Otolaryngology Head & Neck Surgery, Louisiana State University Health Sciences Center, 533 Bolivar Street, Suite 566 New, Orleans, LA 70112, USA. Electronic address: rwalve@lsuhsc.edu.

PMID: 35344693
DOI: 10.1016/j.suc.2022.01.001

Abstract

In this section, we discuss the management of benign salivary gland disease. Pathologies vary from sialolithiasis, salivary duct stenosis, sialadenitis, infectious glandular disease, autoimmune glandular disease, and radioactive iodine-induced disease. We discuss both novel techniques in the diagnosis and management of these diseases, including ultrasound, sialendoscopy, minor salivary gland biopsy, and botulinum toxin injection, which allow for both the alleviation of symptoms and gland preservation.

Keywords: Autoimmune salivary disease; Salivary duct stenosis; Sialadenitis; Sialolithiasis.

Publication types

Review

MeSH terms

Humans
Iodine Radioisotopes
Salivary Gland Calculi* / diagnosis
Salivary Gland Calculi* / therapy
Salivary Glands
Thyroid Neoplasms*
Treatment Outcome

Substances

Iodine Radioisotopes